<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee18037c391">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <namePart>Health, Education, and Human Services Division</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">1999-10-29</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>30 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:HEHS/AIMD-00-36</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-AIMD-00-36</identifier>
<identifier type="local">P0b002ee18037c391</identifier>
<identifier type="former package identifier">f:h100036</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-28</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-HEHS-AIMD-00-36</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-HEHS-AIMD-00-36</accessId>
 <reportNumber>HEHS/AIMD-00-36</reportNumber>
 <subject>Internal controls</subject>
 <subject>Noncompliance</subject>
 <subject>Medical supplies</subject>
 <subject>Inventory control systems</subject>
 <subject>Terrorism</subject>
 <subject>Chemical warfare</subject>
 <subject>Biological warfare</subject>
 <subject>Emergency preparedness</subject>
 <identifier>CDC National Pharmaceutical Stockpile Program</identifier>
 <type>Letter Report</type>
 <seriesAbbrev>HEHS</seriesAbbrev>
 <seriesAbbrev>AIMD</seriesAbbrev>
 <law congress="93" isPrivate="false" number="288"></law>
 <law congress="105" isPrivate="false" number="277"></law>
</extension>
<titleInfo>
 <title>Combating Terrorism: Chemical and Biological Medical</title>
</titleInfo>
<abstract>Pursuant to a congressional request, GAO reviewed the federal
government&apos;s management of chemical and biological medical supplies,
focusing on the: (1) accuracy and currency of the inventory tracking
systems for federal medical stockpiles that would be used to treat the
civilian population following a chemical or biological terrorist attack;
and (2) internal controls in place to manage the stockpiles.&lt;p/&gt;GAO noted that: (1) the U.S. ability to effectively respond to chemical
or biological terrorist incidents is compromised by poor management
controls and the lack of required items; (2) GAO&apos;s physical inventory of
the Office of Emergency Preparedness&apos; (OEP) stockpiles, which the
Department of Veterans Affairs (VA) manages, compared with OEP&apos;s
required list showed a discrepancy of more than 12 percent; (3) although
most discrepancies were overages, GAO also found shortages; (4) GAO
found 3,400 excess gloves at one location and 400 extra diazepam vials
at another; (5) GAO also found that the inventory was short of 1,000
required diazepam injectors at one location and another location had 500
fewer vials of diazepam than required; (6) in addition, when GAO
compared its inventory with VA&apos;s inventory records, GAO found expired
items; (7) at one location, the entire amount of amyl nitrate listed in
VA&apos;s records had expired 8 months before GAO&apos;s visit, and at another
location GAO found more than 400 vials of pralidoxime whose expiration
date was recorded incorrectly; (8) in comparing the Marine Corps
Chemical Biological Incident Response Force&apos;s (CBIRF) medical supplies
with the records in its inventory tracking system, for approximately 26
percent of the inventory items GAO found either discrepancies between
the inventory records and the amount in stock or errors in the recording
of lot numbers and expiration dates; (9) the principal cause of problems
GAO identified is that the responsible federal agencies did not
implement basic internal controls that would reasonably assure that all
medical supplies and pharmaceuticals are current, accounted for, and
available for use; (10) consistent with the Federal Managers&apos; Financial
Integrity Act of 1982, agencies should have efficient and effective
internal controls over their operations and programs; (11) neither OEP
nor CBIRF explained its lack of compliance, and GAO identified problems
in all major aspects of internal controls; (12) as a result, these
systems cannot be relied upon to consistently and accurately account for
the items required to be in the stockpiles; (13) even more will be at
stake in the future as the Centers for Disease Control and Prevention
(CDC) establishes the National Pharmaceutical Stockpile Program; and
(14) although CDC is still in the early phases of developing this
program, its current plan does not include comprehensive internal
controls to prevent the types of problems found at the other agencies.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-HEHS-AIMD-00-36/html/GAOREPORTS-HEHS-AIMD-00-36.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-HEHS-AIMD-00-36/pdf/GAOREPORTS-HEHS-AIMD-00-36.pdf</url>
</location>
<identifier type="preferred citation">GAO/HEHS/AIMD-00-36</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-AIMD-00-36</url>
</location>
<note>Letter Report</note>
<extension>
 <searchTitle>GAO/HEHS/AIMD-00-36; Combating Terrorism: Chemical and Biological Medical;
            </searchTitle>
</extension>
<subject>
 <topic>Internal controls</topic>
 <topic>Noncompliance</topic>
 <topic>Medical supplies</topic>
 <topic>Inventory control systems</topic>
 <topic>Terrorism</topic>
 <topic>Chemical warfare</topic>
 <topic>Biological warfare</topic>
 <topic>Emergency preparedness</topic>
 <topic>CDC National Pharmaceutical Stockpile Program</topic>
</subject>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Public Law 288 (93rd Congress)</title>
</titleInfo>
 <identifier type="public law citation">Public Law 93-288</identifier>
</relatedItem>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Public Law 277 (105th Congress)</title>
</titleInfo>
 <identifier type="public law citation">Public Law 105-277</identifier>
</relatedItem>
</mods>